{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T13:03:24Z","timestamp":1793624604764,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004348","name":"Region Stockholm","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["101003666"],"award-info":[{"award-number":["101003666"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018713","name":"Center for Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omta.2026.201710","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T16:16:22Z","timestamp":1772295382000},"page":"201710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A phase 1 clinical trial of a multi-antigen SARS-CoV DNA vaccine as a booster after dose three spike-based mRNA vaccinations"],"prefix":"10.1016","volume":"34","author":[{"given":"Soo","family":"Aleman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustaf","family":"Ahl\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian An Binh","family":"Nordentoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Appelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlisa","family":"Alisjahbana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Cadossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Salati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Tuvesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Tegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Karin","family":"Gidlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urban","family":"H\u00f6glund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Buggert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Hober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Frelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mirazimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8858-5132","authenticated-orcid":false,"given":"Matti","family":"S\u00e4llberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201710_bib1","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1056\/NEJMoa2102214","article-title":"Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant","volume":"384","author":"Madhi","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201710_bib2","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201710_bib3","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa2103055","article-title":"Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant","volume":"384","author":"Shinde","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201710_bib4","article-title":"Comparative effectiveness of 3 or 4 doses of mRNA and inactivated whole-virus vaccines against COVID-19 infection, hospitalization and severe outcomes among elderly in Singapore","volume":"29","author":"Tan","year":"2022","journal-title":"Lancet Reg. Health West. Pac."},{"key":"10.1016\/j.omta.2026.201710_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa2203965","article-title":"Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections","volume":"387","author":"Altarawneh","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201710_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-immunol-083122-043054","article-title":"SARS-CoV-2: The Interplay Between Evolution and Host Immunity","volume":"43","author":"Case","year":"2025","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.omta.2026.201710_bib7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41590-024-02052-z","article-title":"Variants and vaccines impact nasal immunity over three waves of SARS-CoV-2","volume":"26","author":"Walsh","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omta.2026.201710_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/imr.13431","article-title":"Structural Immunology of SARS-CoV-2","volume":"329","author":"Yuan","year":"2025","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.omta.2026.201710_bib9","doi-asserted-by":"crossref","first-page":"869","DOI":"10.15585\/mmwr.mm7339a2","article-title":"COVID-19-Associated Hospitalizations Among U.S. Adults Aged \u226518 Years - COVID-NET, 12 States, October 2023-April 2024","volume":"73","author":"Taylor","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.omta.2026.201710_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg9452","article-title":"Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states","volume":"15","author":"M\u00fcller","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omta.2026.201710_bib11","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202215821","article-title":"A universal SARS-CoV DNA vaccine inducing highly cross-reactive neutralizing antibodies and T cells","volume":"14","author":"Appelberg","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omta.2026.201710_bib12","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ymthe.2024.01.007","article-title":"Distinct roles of vaccine-induced SARS-CoV-2-specific neutralizing antibodies and T cells in protection and disease","volume":"32","author":"Yan","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201710_bib13","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the Treatment of Covid-19 - Final Report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201710_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1473-3099(23)00650-3","article-title":"Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial","volume":"24","author":"Oda","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.omta.2026.201710_bib15","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1016\/j.vaccine.2023.05.051","article-title":"Immunogenicity and safety of a fourth homologous dose of NVX-CoV2373","volume":"41","author":"Alves","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.omta.2026.201710_bib16","article-title":"Effectiveness of the fourth dose of COVID-19 vaccines against severe COVID-19 among adults 40 years or older in Brazil: a population-based cohort study","volume":"34","author":"Lazar Neto","year":"2024","journal-title":"Lancet Reg. Health Am."},{"key":"10.1016\/j.omta.2026.201710_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13216538","article-title":"Antibody Response After a Fifth Dose (Third Booster) of BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers","volume":"13","author":"Saiag","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.omta.2026.201710_bib18","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/s41591-022-01836-w","article-title":"An early warning system for emerging SARS-CoV-2 variants","volume":"28","author":"Subissi","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201710_bib19","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/gutjnl-2022-327216","article-title":"Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections","volume":"72","author":"Burm","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.omta.2026.201710_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41564-020-00815-6","article-title":"A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model","volume":"6","author":"Hawman","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.omta.2026.201710_bib21","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/mt.2013.119","article-title":"Therapeutic DNA vaccination using in vivo electroporation followed by standard of care therapy in patients with genotype 1 chronic hepatitis C","volume":"21","author":"Weiland","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201710_bib22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201710_bib23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201710_bib24","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41591-022-01700-x","article-title":"Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant","volume":"28","author":"Gao","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201710_bib25","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.chom.2023.04.015","article-title":"Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpox","volume":"31","author":"Adamo","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.omta.2026.201710_bib26","doi-asserted-by":"crossref","first-page":"e01279-20","DOI":"10.1128\/JVI.01279-20","article-title":"The SARS-CoV-2 N Protein Is a Good Component in a Vaccine","volume":"94","author":"Ahl\u00e9n","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201710_bib27","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.4049\/jimmunol.179.7.4741","article-title":"In vivo Electroporation Enhances the Immunogenicity of Hepatitis C Virus Nonstructural3\/4A DNA by Increased Local DNA Uptake, Protein Expression, Inflammation, and Infiltration of CD3+ cells","volume":"179","author":"Ahl\u00e9n","year":"2007","journal-title":"J. Immunol."}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26000455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26000455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:28:57Z","timestamp":1788553737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26000455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S3117387X26000455"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201710","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phase 1 clinical trial of a multi-antigen SARS-CoV DNA vaccine as a booster after dose three spike-based mRNA vaccinations","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201710","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201710"}}